HMECX Mutual Fund (NexPoint Merger Arbitrage Fund Class C) is managed by NexPoint with $21.2M in net assets. HMECX expense ratio is 2.90%, holding 68 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2016-08-19.

HMECX performance shows a YTD return of 1.38%. The 1-year return is 4.02% and the 5-year return is 4.31%. HMECX dividend yield stands at 4.34%, paid quarterly.

HMECX top holdings include Ceridian Hcm Holding Inc (7.8%), Cyberark Softwar (6.2%), Avidity Biosciences Inc. (4.9%), Cidara Therapeutics, Inc. (4.9%), Sealed Air Corp. (4.9%). View all HMECX holdings, sector breakdown, or dividend history.

HMECX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HMECX alternatives are available via the screener, along with tax-loss harvesting opportunities.